New Republic Capital »

SPDR S&P Pharmaceuticals shares owned by New Republic Capital

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by New Republic Capital from 13F filings

Historical chart of New Republic Capital investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by New Republic Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by New Republic Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $22k 338 66.27
2024-06-30 $42k 1.1k 39.78

More positions owned by New Republic Capital

Apple (AAPL)
Gmo Etf Trust Us Quality Etf (QLTY)
Morgan Stanley Com New (MS)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 3000 Etf (IWV)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
First Tr Exchange-traded No Amer Energy (EMLP)
Doubleline Etf Trust Mortgage Etf (DMBS)
Ishares Msci Japan Etf (EWJ)
Alphabet Cap Stk Cl A (GOOGL)
Norfolk Southern (NSC)
Ishares Tr Msci Eafe Etf (EFA)
Amazon (AMZN)

View all positions for New Republic Capital

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
CWM
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Branch Banking & Trust Company
Measured Wealth Private Client Group
Private Advisor
UBS Group
Susquehanna International
Citigroup

View all funds holding SPDR S&P Pharmaceuticals